Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications.
about
The Use of Cardiac Magnetic Resonance in Patients with Suspected Coronary Artery Disease: A Clinical Practice PerspectiveCardiovascular magnetic resonance physics for clinicians: Part II.Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyMyocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass graftingComputed Tomography and Cardiac Magnetic Resonance in Ischemic Heart DiseaseInfluence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.T2-weighted imaging to assess post-infarct myocardium at risk.Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.A technique for in vivo mapping of myocardial creatine kinase metabolism.Microvascular obstruction assessed by 3-tesla magnetic resonance imaging in acute myocardial infarction is correlated with plasma troponin I levels.Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty.Utility of cardiac magnetic resonance for evaluation of mitral regurgitation prior to mitral valve surgery.The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trialFree-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients.Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routineRecent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.In vivo contrast free chronic myocardial infarction characterization using diffusion-weighted cardiovascular magnetic resonance.Third universal definition of myocardial infarction.Utility of magnetic resonance imaging in the evaluation of patients with ST segment elevation on an electrocardiogramCardiovascular MRI in clinical trials: expanded applications through novel surrogate endpointsComparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths.Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction.Reduction of QTD--A Novel Marker of Successful Reperfusion in NSTEMI. Pathophysiologic Insights by CMRPET/MRI of inflammation in myocardial infarction.Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction.Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-RiskMagnetic resonance imaging in the diagnostics of myocardial infarction.Multislice computed tomography angiography in the diagnosis of coronary artery disease.Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinicAlström syndrome: cardiac magnetic resonance findings.The utility of cardiac magnetic resonance imaging in Kounis syndromeConcordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic CardiomyopathyMyocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage.Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease.Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonanceMRI in acute myocardial infarction.The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.
P2860
Q26745987-F93AD7A0-8450-4ACC-A82F-2D7183CD0BB4Q26852691-58F41253-2771-4905-B1E6-96745AE5BEA4Q26999424-9D86F9AC-73A7-477A-9C96-30CBD9A4CF79Q27300772-29DF3B35-21CD-485C-B780-58D3E5BD6899Q28066080-ACD443AB-BFD9-4071-B44F-F07DA2785277Q30278892-F050BBC1-7B68-41B2-8D89-BACFEB4C5228Q30418614-7D655986-1A5D-496B-A702-B3EAF5D87B18Q30425254-761656D2-E815-4D86-A116-810AF8AD4416Q30472637-25292611-B196-42A3-BBE9-AE94C0790A2EQ30731140-470F28AC-3E1A-4BFA-AEDB-6A8B7A7CE730Q33578251-E717EE5E-0238-440F-828B-C781D7986DB8Q33645924-10016FDB-B329-4882-A4B2-36DBDF0C911DQ33650726-55F5DE63-828A-4604-91DB-A3DD2A1345FEQ33728792-44C69D34-ACF2-445C-B94F-B72002368EB0Q33789865-0C3A597E-8A86-4080-81EA-787C250E2FF0Q33853247-D34D2633-69B7-4D0D-B44A-6A8C811D28F2Q34068784-FA7D6B93-7B4B-4F0C-8C54-43FE5B0326B8Q34147112-B8AF5180-24F5-4D93-98BD-FE567FB39A62Q34203641-234C4210-E1CB-41CC-9717-360BFC7F4BF1Q34295914-CC19B5EA-B06B-484A-9A46-867525F9BB66Q35109673-6C893FD4-C000-4A3D-BB20-A37502CDFD91Q35124348-7DB7085B-C353-4358-91A3-F17065DD4BDBQ35141223-C55301F5-14FB-4F0E-8A60-B654736D7A5EQ35240779-D53C3833-BBD6-4FF8-B2DA-5C1511B7CFAAQ35635501-B6E4C944-B960-4F14-849D-5D88D2CA46E2Q35671349-30146E8C-0BFD-4223-AD5D-B279C19B5D17Q35852714-DFF97CB4-F2CD-45B2-8502-105DAFA8CB7AQ35854853-AB6431AE-CA37-406B-AF0B-D6A9BF7AD35CQ36076780-BEAEFC41-3C32-45F6-B405-18D0FB035A6CQ36077289-9ED2C23C-5D89-4219-8E7E-003B7BBF4344Q36095916-032F0BB9-23A1-4ECE-8160-41E01E1347F2Q36174413-5EE54DC5-5A14-44FC-A2BE-87A5E920891BQ36245046-F5167F0D-CD7F-47FA-B260-13AD9A96EA53Q36485009-42E1EE30-0CAC-451C-9FA1-8EEC3F5B975CQ36836362-2A2A1289-8294-440D-BA3F-A86EBD201C64Q36985753-4D14BD98-06F0-4E3A-80F2-C30646C25190Q37090723-0D21C8F1-EF80-40CD-9A39-076ABCE8BDC2Q37569392-FF15677E-FBD7-4027-A7F7-20DD62EF4AA4Q37812993-657EEC90-2BBC-419C-85C8-7461ADE37CE9Q37822294-2382EEEA-AE09-428B-8070-897FF3F6BB9E
P2860
Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular magnetic resona ...... ent and emerging applications.
@en
Cardiovascular magnetic resona ...... ent and emerging applications.
@nl
type
label
Cardiovascular magnetic resona ...... ent and emerging applications.
@en
Cardiovascular magnetic resona ...... ent and emerging applications.
@nl
prefLabel
Cardiovascular magnetic resona ...... ent and emerging applications.
@en
Cardiovascular magnetic resona ...... ent and emerging applications.
@nl
P2093
P921
P1476
Cardiovascular magnetic resona ...... ent and emerging applications.
@en
P2093
Afshin Farzaneh-Far
Raymond J Kim
P356
10.1016/J.JACC.2009.06.059
P407
P577
2009-12-01T00:00:00Z